The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis

[1]  Junbai Wang,et al.  Nuclear IL-33 restrains the early conversion of fibroblasts to an extracellular matrix-secreting phenotype , 2021, Scientific reports.

[2]  R. Pepperkok,et al.  An integrated multiomic and quantitative label-free microscopy-based approach to study pro-fibrotic signalling in ex vivo human precision-cut lung slices , 2020, European Respiratory Journal.

[3]  N. Kaminski,et al.  The Idiopathic Pulmonary Fibrosis Cell Atlas. , 2020, American journal of physiology. Lung cellular and molecular physiology.

[4]  D. Flint,et al.  Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis , 2020, Nature Communications.

[5]  A. McKenzie,et al.  Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages , 2020, Immunity.

[6]  S. Sansom,et al.  GM-CSF drives dysregulated hematopoietic stem cell activity and pathogenic extramedullary myelopoiesis in experimental spondyloarthritis , 2020, Nature Communications.

[7]  M. Strek,et al.  Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat , 2019, Respiratory Research.

[8]  S. Majewski,et al.  Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis: A pilot study , 2019, The clinical respiratory journal.

[9]  N. Todd,et al.  Identification of the IL-33 protein segment that controls subcellular localization, extracellular secretion, and functional maturation. , 2019, Cytokine.

[10]  J. Stewart,et al.  Pellino-1 Regulates the Responses of the Airway to Viral Infection , 2018, Frontiers in Cellular and Infection Microbiology.

[11]  K. Gourgoulianis,et al.  IL-33/ST2 Axis in Organ Fibrosis , 2018, Front. Immunol..

[12]  E. S. Cohen,et al.  New perspectives on IL-33 and IL-1 family cytokines as innate environmental sensors. , 2018, Biochemical Society transactions.

[13]  B. Ryffel,et al.  The IL-33 Receptor ST2 Regulates Pulmonary Inflammation and Fibrosis to Bleomycin , 2018, Front. Immunol..

[14]  Zhe Wu,et al.  An ST2‐dependent role of bone marrow‐derived group 2 innate lymphoid cells in pulmonary fibrosis , 2018, The Journal of pathology.

[15]  C. Newby,et al.  A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis , 2018, Scientific Reports.

[16]  J. Girard,et al.  Interleukin‐33 (IL‐33): A nuclear cytokine from the IL‐1 family , 2018, Immunological reviews.

[17]  N. Todd,et al.  The full-length interleukin-33 (FLIL33)–importin-5 interaction does not regulate nuclear localization of FLIL33 but controls its intracellular degradation , 2017, The Journal of Biological Chemistry.

[18]  S. Uh,et al.  Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis , 2017, BMC Pulmonary Medicine.

[19]  S. Offermanns,et al.  Loss of epithelial Gq and G11 signaling inhibits TGFβ production but promotes IL-33–mediated macrophage polarization and emphysema , 2016, Science Signaling.

[20]  B. Monsarrat,et al.  Extracellular IL-33 cytokine, but not endogenous nuclear IL-33, regulates protein expression in endothelial cells , 2016, Scientific Reports.

[21]  F. Liew,et al.  Interleukin-33 in health and disease , 2016, Nature Reviews Immunology.

[22]  P. Weinreb,et al.  αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease , 2015, European Respiratory Journal.

[23]  J. Bessa,et al.  Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation. , 2014, Journal of autoimmunity.

[24]  Li Zhang,et al.  IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice , 2014, The Journal of allergy and clinical immunology.

[25]  P. Weinreb,et al.  Influenza Promotes Collagen Deposition via αvβ6 Integrin-mediated Transforming Growth Factor β Activation* , 2014, The Journal of Biological Chemistry.

[26]  C. Vancheri,et al.  Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[27]  W. Coward,et al.  A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  D. Vaux,et al.  RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis , 2014, Cell.

[29]  A. Nagarsekar,et al.  Interleukin-33 potentiates bleomycin-induced lung injury. , 2013, American journal of respiratory cell and molecular biology.

[30]  J. Papadimitriou,et al.  Full-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent Fashion , 2012, The Journal of Immunology.

[31]  W. Carver,et al.  Effects of interleukin-33 on cardiac fibroblast gene expression and activity. , 2012, Cytokine.

[32]  Richard T. Lee,et al.  Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells* , 2012, The Journal of Biological Chemistry.

[33]  R. Le Goffic,et al.  Infection with influenza virus induces IL-33 in murine lungs. , 2011, American journal of respiratory cell and molecular biology.

[34]  M. Kawaguchi,et al.  Expression and Effects of IL-33 and ST2 in Allergic Bronchial Asthma: IL-33 Induces Eotaxin Production in Lung Fibroblasts , 2011, International Archives of Allergy and Immunology.

[35]  H. Kita,et al.  The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses , 2011, The Journal of Immunology.

[36]  P. Minoo,et al.  Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis. , 2011, The Journal of clinical investigation.

[37]  A. Matsuda,et al.  IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells , 2010, The Journal of Immunology.

[38]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[39]  G. Raghu,et al.  Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology , 2010, European Respiratory Journal.

[40]  Qutayba Hamid,et al.  Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1 , 2009, The Journal of Immunology.

[41]  S. Cullen,et al.  Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. , 2009, Immunity.

[42]  J. Girard,et al.  The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 , 2009, Proceedings of the National Academy of Sciences.

[43]  M. Hayakawa,et al.  Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation* , 2007, Journal of Biological Chemistry.

[44]  A. Nicholson,et al.  Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. , 2005, The American journal of pathology.

[45]  S. Tominaga,et al.  The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. , 2003, Chest.

[46]  B. Milleron,et al.  Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF‐β and IL-10 , 2003, European Respiratory Journal.

[47]  P. Erne,et al.  Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. , 1999, The American journal of physiology.

[48]  J M Simpson,et al.  Simple method of estimating severity of pulmonary fibrosis on a numerical scale. , 1988, Journal of clinical pathology.

[49]  Xiuhe Pan,et al.  Lentivirus expressing soluble ST2 alleviates bleomycin-induced pulmonary fibrosis in mice. , 2016, International immunopharmacology.

[50]  S. Rosselot.  Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[51]  Nicola J. Rinaldi,et al.  Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation , 2008 .

[52]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..